I was reading a fascinating piece in High Times this morning about the exploding market for MDMA gummies, DMT vape cartridges, mushroom chocolates, and a growing list of psychedelic products finding their way into smoke shops, websites, and social media feeds around the world. The article painted a picture that felt very familiar to anyone who has followed cannabis over the … [Read more...] about Smoke Shops, Mushroom Gummies, and the Next Gray Market
psilocybin
South Dakota Pre-Approves Synthetic Psilocybin—Now It’s Up to the Feds
South Dakota just made a quiet but pretty bold move into the psychedelic conversation—but with a big asterisk attached.The governor has signed a bill that would legalize a synthetic form of psilocybin—but only if the federal government gives it the green light first. In other words, the state is getting ready for something that isn’t fully legal yet, but might be soon.The law … [Read more...] about South Dakota Pre-Approves Synthetic Psilocybin—Now It’s Up to the Feds
🍄 “Live Free or Trip?” — New Hampshire House Backs Therapeutic Psilocybin Plan
New Hampshire lawmakers are dipping a toe into psychedelic reform after the state House approved legislation that would allow psilocybin to be used in a regulated therapeutic setting.The proposal authorizes medical use for certain qualifying conditions and calls for building a state oversight framework within the Department of Health and Human Services, including the creation … [Read more...] about 🍄 “Live Free or Trip?” — New Hampshire House Backs Therapeutic Psilocybin Plan
Massachusetts Takes a Psychedelic Leap
In a landmark development for mental health policy, Massachusetts lawmakers have paved the way for the legal therapeutic use of psilocybin. On Friday, the state’s Joint Committee on Public Health advanced two key bills: one establishing a regulatory framework for psilocybin therapy, and another specifically targeting relief for veterans, first responders, and qualifying … [Read more...] about Massachusetts Takes a Psychedelic Leap
New York Assembly Holds First Public Hearing on Medicinal Psilocybin Use
The New York State Assembly held its first-ever public hearing on the potential therapeutic use of psilocybin, the psychoactive compound found in certain mushrooms. Organized by the Assembly Committee on Health and chaired by Assemblywoman Amy Paulin, the event brought together medical professionals, advocates, researchers, and individuals with firsthand experience to discuss … [Read more...] about New York Assembly Holds First Public Hearing on Medicinal Psilocybin Use
Psilocybin and Mental Health: Scientific Hope or Mere Alchemy?
In 2016, psychiatrist Dr. Benjamin Kelmendi found himself confronting an unexpected mystery. Two of his patients, both struggling with severe, treatment-resistant obsessive-compulsive disorder (OCD), abruptly disappeared from therapy. They had been candidates for deep brain stimulation—an invasive last resort when all else fails. Months later, both returned, transformed and … [Read more...] about Psilocybin and Mental Health: Scientific Hope or Mere Alchemy?
Study Finds “Magic Mushroom” Edibles Contain No Psilocybin and Numerous Undisclosed Substances
A recent investigation has revealed that edibles marketed as “magic mushroom” products may not contain any of the expected psychoactive compound psilocybin. In addition, many of these products carry other active ingredients that were neither listed on their packaging nor subjected to sufficient safety evaluation. Key Findings Public Health Implications Legal … [Read more...] about Study Finds “Magic Mushroom” Edibles Contain No Psilocybin and Numerous Undisclosed Substances
Missouri Would Allocate $10 Million from Opioid Settlement to Psilocybin Research in New Budget Bill
The House of Representatives in Missouri has approved a budget bill that allocates $10 million from the state’s opioid settlement funds for research grants. But not just any research grants. These are intended to explore the effectiveness of psilocybin in treating opioid use disorder, which is currently considered a public health crisis in the United States. Originally, thanks … [Read more...] about Missouri Would Allocate $10 Million from Opioid Settlement to Psilocybin Research in New Budget Bill
Amended Maine Bill To Establish Psychedelic Research Committee Heads to Gov.
Among the many states currently looking to enact measures to investigate psychedelic regulation and increase psychedelic research, Maine is one of the latest to throw its hat in the ring. Lawmakers supporting the initial reform bill were hoping to usher in a new era of psychedelic drug regulation for therapeutic use, though the amended bill would pump the breaks and instead set … [Read more...] about Amended Maine Bill To Establish Psychedelic Research Committee Heads to Gov.
Beyond Cannabis: The Rise of Psilocybin in Connecticut
The air hung heavy with anticipation as the legislative Judiciary Committee convened in the hallowed halls of the Connecticut State Capitol. Their mission? To grapple with the mind-bending question that had infiltrated the collective consciousness: Should the possession of “magic” mushrooms be decriminalized? The stakes were high, my friends, higher than a stoned giraffe on a … [Read more...] about Beyond Cannabis: The Rise of Psilocybin in Connecticut
